1 year return (CAGR)
-41.68%
Telix Pharmaceuticals Limited Exchange (NASDAQ, USD)
TLX
11.27
-0.45 (-4.05%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-25.71%
5 year return (CAGR)
-3.82%
10 year return (CAGR)
-0.31%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
3.61B
Price/Sales
1.81
Ent value
4.55B
Price/Book
-
Div yield
32.83%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
92.17
PEG
-
Forward P/E
30.94
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 11.05 |
| Daily high | 11.05 |
| Daily low | 10.61 |
| Daily Volume | 142K |
| All-time high | 39.51 |
| 1y analyst estimate | 21.57 |
| Beta | 0.60 |
| EPS (TTM) | 0.23 |
| Dividend per share | 3.50 |
| Ex-div date | 18 Apr 2006 |
| Next earnings date | 18 Feb 2026 |
Downside potential
Loading...
Downside potential data
| TLX | S&P500 | |
| Current price drop from All-time high | -71.48% | -1.29% |
| Highest price drop | -98.58% | -56.47% |
| Date of highest drop | 31 Jan 2018 | 9 Mar 2009 |
| Avg drop from high | -49.98% | -10.68% |
| Avg time to new high | 78 days | 12 days |
| Max time to new high | 2902 days | 1805 days |
News
